scholarly journals Exam 2: Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease

2016 ◽  
Vol 14 (11) ◽  
pp. e137
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Liver Disease ◽  
End Stage Liver Disease ◽  
End Stage

Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era

2010 ◽  
Vol 210 (5) ◽  
pp. 727-734 ◽  
Author(s):  
David M. Levi ◽  
Andreas G. Tzakis ◽  
Paul Martin ◽  
Seigo Nishida ◽  
Eddie Island ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Liver Disease ◽  
End Stage Liver Disease ◽  
End Stage

Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma

2019 ◽  
Vol 8 (12) ◽  
pp. 993-1002
Author(s):  
Nima Kokabi ◽  
Nariman Nezami ◽  
Minzhi Xing ◽  
Johannes M Ludwig ◽  
Mario Strazzabosco ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Overall Survival ◽  
Liver Disease ◽  
Organ Procurement ◽  
Group Versus ◽  
Disease Score ◽  
End Stage Liver Disease ◽  
End Stage ◽  
United Network

Aim: To simulate effects of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy on the patients’ characteristics and post orthotopic liver transplantation (OLT) outcome. Materials & methods: The United Network for Organ Sharing database was used to identify patients with hepatocellular carcinoma who were listed for OLT 2002–2014. All patients (actual group) versus simulated group with new 6-month delay in assigning Model for End-Stage Liver Disease score exception and Model for End-Stage Liver Disease exception cap of 34 were compared. Results & conclusion: With the new policy, 7,745 (30.4%) of the transplanted patients would have received a delayed transplantation or not be transplanted. The simulated group also showed significantly higher mean overall survival after OLT (p < 0.002) and received more locoreginal treatments (p < 0.001).

Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience

2012 ◽  
Vol 18 (4) ◽  
pp. 423-433 ◽  
Author(s):  
Jason J. Schwartz ◽  
Lisa Pappas ◽  
Heather F. Thiesset ◽  
Gabriela Vargas ◽  
John B. Sorensen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Liver Disease ◽  
End Stage Liver Disease ◽  
End Stage ◽  
National Experience

Frequency and predictors ofde novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era

2008 ◽  
Vol 14 (2) ◽  
pp. 228-234 ◽  
Author(s):  
Carla W. Brady ◽  
Alastair D. Smith ◽  
Karen M. Stechuchak ◽  
Cynthia J. Coffman ◽  
Janet E. Tuttle-Newhall ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Liver Disease ◽  
Orthotopic Liver Transplantation ◽  
End Stage Liver Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document